Incorporating HIV/HCV Prevention, Screening, and Linkage to Care Into Opioid Use Disorder Treatment Settings

In this downloadable slideset, CCO’s expert faculty reviews important strategies for expanding addiction medicine services to include prevention, screening, diagnosis, and linkage to HCV and HIV care for patients with opioid use disorder.
Alain H. Litwin, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.42 MB
Released: September 18, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
American Society of Addiction Medicine
Educational grant provided by:
Gilead Sciences

Related Content

Clinical Care Options (CCO) video of faculty discussion on the implications of emerging ART safety and tolerability data when managing HIV treatment

Joseph J. Eron, Jr., MD Darcy Wooten, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 11, 2021 Expired: May 10, 2022

CCO slides from Drs. Joseph J. Eron, Jr, and Darcy Wooten on the implications of emerging ART safety and tolerability data when managing HIV treatment

Joseph J. Eron, Jr., MD Darcy Wooten, MD Released: May 11, 2021

Clinical Care Options (CCO) presents Howard Grossman, MD, and Cristina Mussini, MD, answering questions on HIV prevention in older individuals

Howard Grossman, MD Cristina Mussini, MD Released: May 6, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue